The Hitchhiker’s Guide to Virotherapy
The Hitchhiker’s Guide to Virotherapy |
|
https://doi.org/10.18632/oncotarget.627
Oliver Donnelly,
Richard Vile,
Hardev Pandha,
Kevin Harrington,
and Alan Melcher
|
| 735-736 |
Infection, inflammation and colon carcinogenesis
Infection, inflammation and colon carcinogenesis |
|
https://doi.org/10.18632/oncotarget.624
Gerald N. Wogan,
Peter C. Dedon,
Steven R. Tannenbaum,
and James G. Fox
|
| 737-738 |
Oncogene addiction to c-MYC in myeloma cells
Oncogene addiction to c-MYC in myeloma cells |
|
https://doi.org/10.18632/oncotarget.631
Toril Holien,
and Anders Sundan
|
| 739-740 |
Shock about heat shock in cancer
Shock about heat shock in cancer |
|
https://doi.org/10.18632/oncotarget.646
Emmanuel de Billy,
Jon Travers,
and Paul Workman
|
| 741-743 |
The promise of anti-ErbB3 monoclonals as new cancer therapeutics
The promise of anti-ErbB3 monoclonals as new cancer therapeutics |
|
https://doi.org/10.18632/oncotarget.550
Luigi Aurisicchio,
Emanuele Marra,
Giuseppe Roscilli,
Rita Mancini,
and Gennaro Ciliberto
|
| 744-758 |
A lesson for cancer research: placental microarray gene analysis in preeclampsia
A lesson for cancer research: placental microarray gene analysis in preeclampsia |
|
https://doi.org/10.18632/oncotarget.595
Frank Louwen,
Cornelia Muschol-Steinmetz,
Josha Reinhard,
Anke Reitter,
and Juping Yuan
|
| 759-773 |
Mutant IDH1 is required for IDH1 mutated tumor cell growth
Mutant IDH1 is required for IDH1 mutated tumor cell growth |
|
https://doi.org/10.18632/oncotarget.577
Genglin Jin,
Christopher J. Pirozzi,
Lee H. Chen,
Christopher G. Duncan,
Giselle Y. Lopez,
Jie Feng,
Ivan Spasojevic,
Darell D. Bigner,
Yiping He,
and Hai Yan
|
| 774-782 |
Systemic shRNA mediated knock-down of S100A4 in colorectal cancer xenografted mice reduces metastasis formation
Systemic shRNA mediated knock-down of S100A4 in colorectal cancer xenografted mice reduces metastasis formation |
|
https://doi.org/10.18632/oncotarget.572
Mathias Dahlmann,
Ulrike Sack,
Pia Herrmann,
Margit Lemm,
Iduna Fichtner,
Peter M. Schlag,
and Ulrike Stein
|
| 783-797 |
Mitochondrial Fission Induces Glycolytic Reprogramming in Cancer-Associated Myofibroblasts, Driving Stromal Lactate Production, and Early Tumor Growth
Mitochondrial Fission Induces Glycolytic Reprogramming in Cancer-Associated Myofibroblasts, Driving Stromal Lactate Production, and Early Tumor Growth |
|
https://doi.org/10.18632/oncotarget.574
Carmela Guido,
Diana Whitaker-Menezes,
Zhao Lin,
Richard G. Pestell,
Anthony Howell,
Teresa A. Zimmers,
Mathew C. Casimiro,
Saveria Aquila,
Sebastiano Ando,
Ubaldo E. Martinez-Outschoorn,
Federica Sotgia,
and Michael P. Lisanti
|
| 798-810 |
Harnessing the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia: Eliminating activity by targeting at different levels
Harnessing the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia: Eliminating activity by targeting at different levels |
|
https://doi.org/10.18632/oncotarget.579
Daniela Bressanin,
Camilla Evangelisti,
Francesca Ricci,
Giovanna Tabellini,
Francesca Chiarini,
Pier Luigi Tazzari,
Fraia Melchionda,
Francesca Buontempo,
Pasqualepaolo Pagliaro,
Andrea Pession,
James A McCubrey,
and Alberto M. Martelli
|
| 811-823 |
Development of gene expression-based risk score in cytogenetically normal acute myeloid leukemia patients
Development of gene expression-based risk score in cytogenetically normal acute myeloid leukemia patients |
|
https://doi.org/10.18632/oncotarget.571
Elias Bou Samra,
Bernard Klein,
Thérèse Commes,
and Jerome Moreaux
|
| 824-832 |
Mislocalization of death receptors correlates with cellular resistance to their cognate ligands in human breast cancer cells
Mislocalization of death receptors correlates with cellular resistance to their cognate ligands in human breast cancer cells |
|
https://doi.org/10.18632/oncotarget.542
Baolin Zhang,
Jun-Jie Chen,
Jennifer H.-C. Shen,
Leslie Rivera Rosado,
Yaqin Zhang,
and Xu Di
|
| 833-842 |
Meta-analysis of clinical data using human meiotic genes identifies a novel cohort of highly restricted cancer-specific marker genes.
Meta-analysis of clinical data using human meiotic genes identifies a novel cohort of highly restricted cancer-specific marker genes. |
|
https://doi.org/10.18632/oncotarget.580
Julia Feichtinger,
Ibrahim Aldeailej,
Rebecca Anderson,
Mikhlid Almatrafi,
Naif Alsiwiehri,
keith Griffiths,
Nicholas Stuart,
Jane A Wakeman,
Lee Larcombe,
and Ramsay James McFarlane
|
| 843-853 |
Regulation of DNA Damage Following Termination of Hedgehog (HH) Survival Signaling at the level of the GLI Genes in Human Colon Cancer
Regulation of DNA Damage Following Termination of Hedgehog (HH) Survival Signaling at the level of the GLI Genes in Human Colon Cancer |
|
https://doi.org/10.18632/oncotarget.586
AKWASI AGYEMAN,
Tapati Mazumdar,
and Janet A Houghton
|
| 854-868 |
Tumor suppression by small molecule inhibitors of translation initiation
Tumor suppression by small molecule inhibitors of translation initiation |
|
https://doi.org/10.18632/oncotarget.598
Limo Chen,
Bertal H Aktas,
Yibo wang,
Xiaoying He,
Rupam Sahoo,
Nancy Zhang,
Severine Denoyelle,
Eihab Kabha,
Hongwei Yang,
Revital Yefidoff Freedman,
Jeffrey G. Supko,
Michael Chorev,
Gerhard Wagner,
and Jose A. Halperin
|
| 869-881 |
Nectin like-5 overexpression correlates with the malignant phenotype in cutaneous melanoma
Nectin like-5 overexpression correlates with the malignant phenotype in cutaneous melanoma |
|
https://doi.org/10.18632/oncotarget.594
Valentina Bevelacqua,
Ylenia Bevelacqua,
Saverio Candido,
Evangelica Skarmoutsou,
Alfredo Amoroso,
Claudio Guarneri,
Angela Strazzanti,
Pietro Gangemi,
Maria Clorinda Mazzarino,
Fabio D'Amico,
James A McCubrey,
Massimo Libra,
and Grazia Malaponte
|
| 882-892 |
The connection between lymphangiogenic signalling and prostaglandin biology: A missing link in the metastatic pathway
The connection between lymphangiogenic signalling and prostaglandin biology: A missing link in the metastatic pathway |
|
https://doi.org/10.18632/oncotarget.593
Tara Karnezis,
Ramin Shayan,
Stephen Fox,
Marc G. Achen,
and Steven A. Stacker
|
| 893-906 |
